Find trials
Search tips

A Study to Develop an Evidence-Based Decision Aid for Patients with Asymptomatic/ Mild Primary Hyperparathyroidism

Overview

About this study

The purpose of this study is to develop and evaluate a treatment decision aid for patients with asymptomatic primary hyperparathyroidism.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Adults ≥ 18 years
  • Diagnosis of Asymptomatic Primary Hyperparathyroidism
  • Appointment with endocrinologist to discuss treatment options

 

Exclusion Criteria

  • Major barriers to participate in shared decision making or to providing informed consent i.e.
    • Dementia
    • Severe hearing or visual impairment

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Victor Montori, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20273183

Mayo Clinic Footer